Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Intangibles (2016 - 2023)

Historic Intangibles for Altimmune (ALT) over the last 11 years, with Q3 2023 value amounting to $12.4 million.

  • Altimmune's Intangibles changed 0.0% to $12.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $12.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $12.4 million for FY2022, which is 989.62% down from last year.
  • Latest data reveals that Altimmune reported Intangibles of $12.4 million as of Q3 2023, which was down 0.0% from $12.4 million recorded in Q2 2023.
  • In the past 5 years, Altimmune's Intangibles ranged from a high of $14.5 million in Q4 2019 and a low of $12.4 million during Q1 2022
  • Over the past 5 years, Altimmune's median Intangibles value was $13.5 million (recorded in 2020), while the average stood at $13.4 million.
  • Its Intangibles has fluctuated over the past 5 years, first plummeted by 6379.81% in 2019, then skyrocketed by 169.18% in 2021.
  • Over the past 5 years, Altimmune's Intangibles (Quarter) stood at $14.5 million in 2019, then dropped by 5.96% to $13.6 million in 2020, then rose by 1.43% to $13.8 million in 2021, then decreased by 9.9% to $12.4 million in 2022, then changed by 0.0% to $12.4 million in 2023.
  • Its Intangibles stands at $12.4 million for Q3 2023, versus $12.4 million for Q2 2023 and $12.4 million for Q1 2023.